Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Convalescent plasma Emergency use authorization Experimental Antiviral Jan/06/2021 26 5
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/24/2020 36 38
Remdesivir Approved by FDA Experimental Antiviral Dec/02/2020 48 4
Doxycycline Potential treatment - clinical evidence Used to treat other disease Antiviral Oct/31/2020 4 0
Almitrine Potential treatment - clinical evidence Used to treat other disease Antiviral Oct/21/2020 3 0
Ad5-nCoV Potential treatment - clinical evidence Experimental Vaccine Aug/14/2020 4 0
Rupintrivir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jul/01/2020 3 0
Ebastine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jun/19/2020 2 0
Sertaconazole Potential treatment - theoretical effect Used to treat other disease Antiviral May/23/2020 1 0
Pimozide Potential treatment - theoretical effect Used to treat other disease Antiviral May/23/2020 1 0